Specific gene expression and therapy for pancreatic cancer using the cytosine deaminase gene directed by the rat insulin promoter

Journal of Gastrointestinal Surgery

Volumn 8, Issue 1, 2004, Pages 98-108

  Wang, Xiao Ping ^a   Yazawa, Kazuyuki ^a   Yang, Jie ^a   Kohn, Deborah ^a   Fisher, William E ^a   Brunicardi, F Charles ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Gene therapy; Pancreatic cancer; Suicide gene; Tissue specific; Transcription factor

Indexed keywords

BETA GALACTOSIDASE; CYTOSINE DEAMINASE; DNA FRAGMENT; FLUCYTOSINE; FLUOROURACIL; INSULIN; TRANSCRIPTION FACTOR PDX 1;

ARTICLE; ASSAY; CANCER CELL; CELL DEATH; CELL ISOLATION; CELL SPECIFICITY; CONTROLLED STUDY; CYTOTOXICITY; DNA PURIFICATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; STAINING; SUICIDE GENE; WESTERN BLOTTING;

EID: 1642423482     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2003.10.008     Document Type: Article

References (31)

1. Brennan M.F. Pancreatic cancer. J. Gastroenterol Hepatol. 15:2000;G13-G16.
2. Yeo C.J., Cameron J.L. Neoplasms of the Pancreas Exocrine Tumors. 5th ed :1997;WB Saunders, Philadelphia.
3. Ahlgreb J.D. Chemotherapy for pancreatic carcinoma. Cancer. 78:1996;S654-S663.
4. Blaszkowsky L. Treatment of advanced and metastatic pancreatic cancer. Front Biosci. 3:1998;214-225.
5. Takeda S., Nakao A., Miyoshi K., et al. Gene therapy for pancreatic cancer. Semin Surg Oncol. 15:1998;57-61.
6. Pearson A.S., Bouvet M., Evans D.B., et al. Gene therapy and pancreatic cancer. Front. Biosci. 3:1998;230-237.
7. Evoy D., Hirschowitz E.A., Naama H.A., et al. In vivo adenoviral-mediated gene transfer in the treatment of pancreatic cancer. J Sur Res. 69:1997;226-231.
8. Haack K., Linnebacher M., Eisold S., et al. Induction of protective immunity against syngeneic rat cancer cells by expression of the cytosine deaminase suicide gene. Cancer Gene Ther. 7:2000;1057-1064.
9. Kanyama H., Tomita N., Yamono T., et al. Usefulness of repeated direct intratumoral gene transfer using hemagglutinating virus of Japan-liposome method for cytosine deaminase suicide gene therapy. Cancer Res. 61:2001;14-18.
10. Harris J.D., Gutierrez A.A., Hurst H.C., et al. Gene therapy for cancer using tumor-specific prodrug activation. Gene Ther. 1:1994;170-175.
11. Burris Hr., Moore M., Andersen J., et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol. 15:1997;2403-2413.
12. Casper E.S., Green M.R., Kelsen D.P., et al. Phase II trial of gemcitabine (2′, 2′-diflurodeoxycytidine) in patients with adenocarcinoma of the pancreas. Invest New Drugs. 12:1994;29-34.
13. Peshavaria M., Henderson E., Sharma A., et al. Functional characterization of the transactivation properties of the PDX-1 homeodomain protein. Mol Cell Biol. 17:1997;3987-3996.
14. Stoffers D.A., Zinkin N.T., Stanojevic V., et al. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet. 15:1997;106-110.
15. Gerrish K., Gannon M., Shih D., et al. Pancreatic beta cell specific transcription of the pdx-1 gene. J Biol Chem. 275:2000;3485-3492.
16. Tirone T., Fagan S., Templeton N., et al. Insulinoma-induced hypoglycemic death in mice is prevented with beta cellspecific gene therapy. Ann Surg. 233:2001;603-611.
17. Tirone T., Lee T., Nguyen L., Brunicardi F.C. Human ductal pancreatic adenocarcinoma (PDA) cells that express PDX-1 can be targeted with a rat insulin promoter thymidine kinase gene. [abstr] J Surg Res. 93:2000;350-351.
18. Mullan M., Gauger P., Thompson N. Endocrine tumors of the pancreas: Review and recent advances. ANZ J Surg. 71:2001;475-482.
19. Kilstrup M., Meng L.M., Neuhard J., et al. Genetic evidence for a repressor of synthesis of cytosine deaminase and purine biosynthesis enzymes in Escherichia coli. J Bacteriol. 171:1989;2124-2127.
20. Austin E.A., Huber B.E. A first step in the development of gene therapy for colorectal carcinoma: Cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol Pharmacol. 43:1993;380-387.
21. Mullen C.A., Kilstrup M., Blaese R.M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system. Proc Natl Acad Sci USA. 89:1992;33-37.
22. Moolten F.L. Drug sensitivity ("suicide") genes for selective cancer chemotherapy. Cancer Gene Ther. 1:1994;279-287.
23. Katsuragi T., Sonoda T., Matsumoto K., et al. Purification and some properties of cytosine deaminase from baker's yeast. Agric Biol Chem. 53:1989;1313-1319.
24. Frazier M. Gene expression in pancreatic adenocarcinoma. Ann N Y Acad Sci. 880:1999;1-4.
25. St-Onge L., Wehr R., Gruss P. Pancreas development and diabetes. Curr Opin Genet Dev. 9:1999;295-300.
26. Sander M., German M. The beta cell transcription factors and development of the pancreas. J Mol Med. 75:1997;327-340.
27. Ahlgren U., Jonsson J., Jonsson L., et al. Beta cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev. 12:1998;1763-1768.
28. Guz Y., Montimity M.R., Stein R., et al. Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development. 121:1995;11-18.
29. Miller C.P., McGehee R.E., Habener J.F. IDX-1: A new homeodomain transcription factor expressed in pancreatic islets and duodenum that transactivates the somatostatin gene. EMBO J. 13:1994;1145-1156.
30. Swift G.H., Liu Y., Rose S.D., et al. An endocrine-exocrine switch in the activity of the pancreatic homeodomain protein PDX1 through formation of a trimeric complex with PBX1b and MRG1 (MEIS2). Mol Cell Biol. 18:1998;5109-5120.
31. Crowe D.T., Tsai M. Mutagenesis of the rat insulin II 5′flanking region defines sequences important for expression in HIT cells. Mol Cell Biol. 9:1989;1784-1789.